ADAR1 Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.9M | Sell |
1,940,797
-1,542,607
| -44% | -$17.4M | 3.35% | 6 |
|
|
2025
Q1 | $35.1M | Sell |
3,483,404
-25,290
| -0.7% | -$255K | 6.52% | 3 |
|
|
2024
Q4 | $41.5M | Buy |
3,508,694
+483,244
| +16% | +$5.72M | 8.3% | 1 |
|
|
2024
Q3 | $34.9M | Sell |
3,025,450
-1,124,559
| -27% | -$13M | 5.68% | 5 |
|
|
2024
Q2 | $43.9M | Buy |
4,150,009
+1,358,139
| +49% | +$14.4M | 8.28% | 3 |
|
|
2024
Q1 | $29.4M | Buy |
2,791,870
+1,535,279
| +122% | +$16.2M | 6.68% | 2 |
|
|
2023
Q4 | $14.1M | Buy |
+1,256,591
| New | +$14.1M | 5.04% | 3 |
|